SCR-LIP-000565 · Claim · machine-readable JSON →
In a prospective cohort of 100 patients with lipedema (average follow-up 4.6 years), the average limb-volume change was 2.8%, with 62% classified as stable (within ±10%), 28% as progressed and 10% as improved; volume change was positively associated with increases in BMI and in waist-to-height ratio, which the authors interpret as a relationship between fat gain and lipedema progression.
This single-paper claim was consolidated into general propositions (R-CLM-19); its evidence now sits under:
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- moderate (GRADE)
- Evidence
- 1 source(s)
- Answers
- 0 question(s)
- Dates
- 2026-11-17 → 2026-11-17
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-11-17
Evidence over time
Evidence (1)
- Is lipedema a progressive disease? (2025) ✓ verified — contextual · cohort · 2025 · risk of bias: high · reading confidence: high
“Stability was observed in 62% of the patients, progression in 28%, and improvement in 10%.”
The cohort found lipedema generally stable, with volume progression driven by weight gain (BMI/WHtR) rather than disease chronicity or stage; lymphoscintigraphic abnormalities were not associated with progression, arguing against inherent pWhy this risk of bias: full-text methodological appraisal (6)
Each point was checked against the full text and is shown with the verbatim passage. Positional or interpretive points were excluded. AI full-text appraisal (Claude), each point checked against the PDF · 2026-11-17
- Not an untreated natural history: most patients were on active conservative treatment, although the paper presents itself as a natural-history study.
“A total of 76% of the patients wore the compression garments prescribed by the doctor and 66% carried out [physical exercise]” - Selection: only 100 of 195 recruited patients (those with two volume measurements) were analysed, and liposuction history was an exclusion criterion, so patients who progressed to surgery may be missing.
“From the 195 patients with lipedema recruited in our prospective cohort from September 2012 to September 2023, those who had at least two volume measurements” - The volume change is taken at the first follow-up (median 3.1 years, SD 1.9), not at the 4.6-year median in the abstract, and the fixed ±10% cut-off is not adjusted for time.
“first follow up had a median of 3.1 years (SD: 1.9) after baseline” - The mean volume change has a confidence interval above zero (net increase), and 28% progressed versus 10% improved; 'stability in 62%' depends on the chosen cut-off.
“The mean PVC was 2.8% (95% CI: 0.6–5.0)” - The case definition requires pain or discomfort, so painless lipedema is excluded by design.
“associated with pain or discomfort in LL” - Lymphatic involvement was frequent in the same cohort (relevant to the lipedema–lymphedema question).
“Lymphoscintigraphic alterations (n = 76) 35/76 (46.1%)”
- Not an untreated natural history: most patients were on active conservative treatment, although the paper presents itself as a natural-history study.
Context (PECO)
Answers these questions
- Not yet linked to a question.
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-11-17 — created · auto-ingested for SQ-LIP-000039
- 2026-11-17 — risk of bias revised · 10.1177/1358863x241306415: risk_of_bias unknown → high, grade moderate → low (GRADE downgrade for serious risk of bias), from a full-text methodological appraisal; 6 points, each with the verbatim passage (rob_appraisal).
- 2026-11-17 — statement revised · Re-anchored to the reported data (CI above zero, first-follow-up interval, compression use) instead of the 'stable / not lipedema itself' framing; stance contradicting → context, the independent verifier's reading (R-AI-14). Then restricted to what the abstract states (the verifier reads the abstract); the full-text figures (CI 0.6–5.0, first follow-up 3.1 years, 76% on compression, 46.1% lymphoscintigraphic abnormalities) live in rob_appraisal with verbatim passages.
- 2026-11-20 — consolidated · SQ-LIP-000039: evidence moved to SCR-LIP-000772